1 / 4

North American Silent heart attack Market Size, Growth Analysis Report, Forecast to 2027

North American silent heart attack market is estimated to grow significantly at a CAGR of around 6.8% during the forecast period. North America contributes the major share in the global silent heart attack treatment market, owing to the rising heart patients, increase in FDA approvals, and favorable government policies for healthcare sector. Moreover, the rising adoption of minimally invasive/non-invasive surgeries and advancement in treatment technology is anticipated to further drive the growth of the market in the region.<br>

Saifiyan
Télécharger la présentation

North American Silent heart attack Market Size, Growth Analysis Report, Forecast to 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. North American Silent heart attack Market Size, Growth Analysis Report, Forecast to 2027 North American Silent heart attack Market Size, Growth Analysis Report, Forecast to 2027 North American Silent heart attack Market: Report Based on Development, Scope, Share, Trends, Forecast to 2027 North American Silent heart attack Market Trends | Segmentation, Outlook, Industry Report to 2021-2027 North American silent heart attack market is estimated to grow significantly at a CAGR of around 6.8% during the forecast period. North America contributes the major share in the global silent heart attack treatment market, owing to the rising heart patients, increase in FDA approvals, and favorable government policies for healthcare sector. Moreover, the rising adoption of minimally invasive/non-invasive surgeries and advancement in treatment technology is anticipated to further drive the growth of the market in the region. Get Free Sample Copy @ https://www.omrglobal.com/request-sample/north-american-silent- heart-attack-market According to WHO, factors such as diabetes, hypertension and obesity are also responsible for rising heart diseases in North America as these factors increases the risk of heart related problems. North America has a considerable market share of cardiovascular stents, catheters, rhythm management and other devices that are used in the treatment of silent heart attack. Moreover, the high cost of drugs and procedures in the US and the significant sale of branded drugs in the region are other factors contributing into the growth of the market.

  2. A Full Report of North American Silent heart attack Market is Available at: https://www.omrglobal.com/industry-reports/north-american-silent-heart-attack-market North American silent heart attack market is segmented into diagnosis, treatment, and end- user. Based on the diagnosis, the market is segmented into an electrocardiography (ECG), chest x-ray, computed tomography (CT Scan), echocardiography, and others (blood test). Based on treatment, the market is segmented into medication and surgery. Based on end-user, the market is segmented into hospitals & clinics and ambulatory surgical centers (ASCs). ECG is the most used technology to diagnose silent heart attack. ECG provides insights about heart rate, indicates, if there is enlargement of the heart due to high blood pressure (hypertension) or evidence of a previous heart attack. The companies which are contributing to the growth of the North American silent heart attack market include Abbott Laboratories Inc., Johnson & Johnson Services Inc., Pfizer Inc., Bayer AG, and Novartis AG. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups, and technological advancements to stay competitive in the market. North American Silent heart attack Market Segmentation North American Silent Heart Attack Market by Diagnosis •Electrocardiography (ECG) •Magnetic Resonance Imaging (MRI) •Computed Tomography (CT Scan) •Echocardiography •Others (Blood Test) North American Silent Heart Attack Market by Treatment •Medication •Surgery oAngioplasty oBypass Surgery oHeart Transplant

  3. North American Silent Heart Attack Market by End-Users •Hospital & Clinics •Ambulatory Surgical Centers North American Silent heart attack Market – Segment by Region North America •United States •Canada Europe •Germany •United Kingdom •France •Spain •Italy •Rest of Europe Asia-Pacific •China •Japan •India •Rest of Asia-Pacific Rest of the World •Latin America •Middle East and Africa

  4. Company Profiles •Astellas Pharma Inc. •AstraZeneca PLC •Bayer AG •Boehringer Ingelheim GmbH •Boston Scientific Corp. •F. Hoffmann-La Roche Ltd. •GlaxoSmithKline Plc •Medtronic PLC •Merck & Co., Inc. •Novartis AG •Pfizer Inc. •Siemens AG •Takeda Pharmaceutical Co. Ltd. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/north-american-silent-heart-attack- market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404

More Related